BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30808202)

  • 1. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
    Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
    Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
    Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
    Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
    Katalinic A; Eisemann N; Kraywinkel K; Noftz MR; Hübner J
    Int J Cancer; 2020 Aug; 147(3):709-718. PubMed ID: 31675126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
    Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study.
    Puliti D; Zappa M; Giorgi Rossi P; Pierpaoli E; Manneschi G; Ambrogetti D; Ventura L; Mantellini P;
    Breast Cancer Res; 2018 Aug; 20(1):95. PubMed ID: 30092817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.
    Kuklinski D; Blum M; Subelack J; Geissler A; Eichenberger A; Morant R
    Breast Cancer Res; 2024 May; 26(1):84. PubMed ID: 38802897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening.
    Steponaviciene L; Vincerzevskiene I; Briediene R; Urbonas V; Vanseviciute-Petkeviciene R; Smailyte G
    Cancer Control; 2019; 26(1):1073274819874122. PubMed ID: 31502471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of advanced-stage breast cancer in regular participants of a mammography screening program: a prospective register-based study.
    Khil L; Heidrich J; Wellmann I; Kääb-Sanyal V; Weigel S; Heindel W; Hense HW; Heidinger O
    BMC Cancer; 2020 Mar; 20(1):174. PubMed ID: 32131766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer incidence and mammography screening among resettlers in Germany.
    Kaucher S; Khil L; Kajüter H; Becher H; Reder M; Kolip P; Spallek J; Winkler V; Berens EM
    BMC Public Health; 2020 Mar; 20(1):417. PubMed ID: 32228537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
    Lousdal ML; Kristiansen IS; Møller B; Støvring H
    Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects.
    Herrmann C; Morant R; Walser E; Mousavi M; Thürlimann B
    BMC Cancer; 2021 Mar; 21(1):229. PubMed ID: 33676446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice.
    Larsen IK; Myklebust TÅ; Johannesen TB; Møller B; Hofvind S
    Breast; 2018 Apr; 38():107-113. PubMed ID: 29306771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.
    Heidinger O; Batzler WU; Krieg V; Weigel S; Biesheuvel C; Heindel W; Hense HW
    Dtsch Arztebl Int; 2012 Nov; 109(46):781-7. PubMed ID: 23264826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
    Sebuødegård S; Botteri E; Hofvind S
    J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines.
    Guo F; Kuo YF; Berenson AB
    Am J Prev Med; 2019 Jan; 56(1):100-108. PubMed ID: 30573138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of breast cancer screening in a population with high spontaneous coverage with mammography.
    Capodaglio G; Zorzi M; Tognazzo S; Greco A; Michieletto F; Fedato C; Montaguti A; Turrin A; Ferro A; Cinquetti S; Russo F; Corti MC; Rugge M; Fedeli U
    Tumori; 2018 Aug; 104(4):258-265. PubMed ID: 30079815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
    de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
    Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of female breast cancer between Russia and Germany: A population-based study on time trends and stage at diagnosis.
    Mahanani MR; Valkov M; Agaeva A; Kaucher S; Pikalova LV; Grishchenko MY; Zhuikova LD; Jaehn P; Winkler V
    Cancer Epidemiol; 2022 Oct; 80():102214. PubMed ID: 35841762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.